Saturday, October 3, 2026

NYSE FANG Rises By 13% In The Last 21 Sessions

NYSE FANG Rises By 13% In The Last 21 Sessions

(VIANEWS) - NYSE FANG (NYFANG) has been up by 13.72% for the last 21 sessions. At 10:10 EST on Wednesday, 3 July, NYSE FANG (NYFANG) is $11,825.98.

Concerning NYSE FANG's yearly highs and lows, it's 68.6% up from its 52-week low and 0.01% down from its 52-week high.

Volatility

NYSE FANG's last week, last month's, and last quarter's current intraday variation average was 0.70%, 0.56%, and 1.09%, respectively.

NYSE FANG's highest amplitude of average volatility was 1.36% (last week), 1.10% (last month), and 1.09% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NYSE FANG's is considered to be oversold (<=20).

News about

  • According to Zacks on Monday, 1 July, "The S&P 500 and the Nasdaq registered quarterly gains of 3.9% and 8.3%, respectively. ", "Both the S&P 500 and the Dow Jones Industrial Average closed 0.1% in the red, while the Nasdaq Composite bucked the trend by rising 0.2%."
  • According to Zacks on Monday, 1 July, "The S&P 500 scaled northward in the first half of 2024 and ended tantalizingly close to its all-time closing high. ", "A blistering rally among tech stocks led by Super Micro Computer, Inc. (SMCI Quick QuoteSMCI - Free Report) , NVIDIA Corporation (NVDA Quick QuoteNVDA - Free Report) and Micron Technology, Inc. (MU Quick QuoteMU - Free Report) helped the broader S&P 500 to close in the green in the first two quarters and squash recession fearmongering."
  • According to FXStreet on Tuesday, 2 July, "Nvidia's projected sales for the next 12 months position it as the most expensive stock in the S&P 500 based on its price-to-sales ratio. "

More news about NYSE FANG (NYFANG).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com